News
Controversial US-backed hepatitis B vaccine trial to move forward in Guinea-Bissau
Summary by The Sahel Editorial Desk Rédaction Africanews , as published by Africanews (EN)
· October 12, 2026
· 1 min read
Photo: Africanews (EN) · view original
A controversial US-backed hepatitis B vaccine trial on newborns was given approval to move forward in Guinea-Bissau last week, despite ethical concerns, according to the Guardian.
Sources and story details Story provenance No corrections
Summary created by The Sahel Editorial Desk — automated, rule-governed Byline on source page Rédaction Africanews, as published by Africanews (EN) Original story Read at the source Source published Oct 12, 2026 Indexed here Oct 14, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
More News Today’s briefing Local events
Frequently asked about this story
What is this story about? A controversial US-backed hepatitis B vaccine trial on newborns was given approval to move forward in Guinea-Bissau last week, despite ethical concerns, according to the Guardian.
When was this published? This article was first published on October 12, 2026 by Africanews (EN) and curated for The Sahel readers.
Who reported this story? This story was reported by Rédaction Africanews at Africanews (EN). To learn more about how The Sahel selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more News coverage from The Sahel, or browse our daily briefing and topic hubs .
← Back to all news
More News →
Today’s briefing
Subscribe to newsletter
